Status:
COMPLETED
Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction
Lead Sponsor:
Severance Hospital
Collaborating Sponsors:
European Institute of Oncology
Changhua Christian Hospital
Conditions:
Postoperative Complications
Recurrence
Eligibility:
FEMALE
Brief Summary
Robotic mastectomy with immediate reconstruction was introduced by Toesca et al. in 2015. Since then, several studies have reported the safety and feasibility of robotic nipple-sparing mastectomy with...
Detailed Description
This study is an international multi-center pooled analysis using prospective and retrospective studies to evaluate surgical and oncologic outcomes of robotic nipple-sparing mastectomy with immediate ...
Eligibility Criteria
Inclusion
- Women who underwent nipple sparing mastectomy and immediate reconstruction
- Women with early breast cancer
- Women with germline BRCA 1/2 mutation or germline mutations in genetic susceptibility genes
- Women with interstitial mastopathy
- Women with risk-reducing mastectomy or contralateral mastectomy
Exclusion
- Male patients
- Women with stage IV disease at diagnosis
- Women who underwent previous breast cancer surgery
- Women who received prior radiotherapy for the ipsilateral breast
Key Trial Info
Start Date :
May 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 18 2022
Estimated Enrollment :
659 Patients enrolled
Trial Details
Trial ID
NCT04108117
Start Date
May 14 2020
End Date
May 18 2022
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University College of Medicine
Seoul, South Korea, 120-752